Mutation, replicative infidelity of DNA and aneuploidy sequentially in the formation of malignant pleomorphic tumors

Histology and Histopathology

Volumn 22, Issue 1-3, 2007, Pages 321-326

  Bignold, Leon P ^a  

^a INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

Author keywords

Aneuploidy; Chromosomes; DNA replication; Fidelity; Hyperploidy; Immortality; Mitosis; Tumors

Indexed keywords

DNA; MUTAGENIC AGENT;

ANEUPLOIDY; CANCER CELL; CANCER GENETICS; CARCINOGENESIS; CHROMOSOMAL INSTABILITY; GENE MUTATION; GENE REPLICATION; GENE SEQUENCE; GENOMICS; HUMAN; KARYOTYPE; MALIGNANT NEOPLASTIC DISEASE; MITOSIS; MOLECULAR MECHANICS; MUTAGENESIS; PATHOGENESIS; PLEOMORPHIC ADENOMA; REVIEW; SOMATIC CELL; TUMOR GROWTH;

ANEUPLOIDY; DNA REPLICATION; DNA, NEOPLASM; GENOMIC INSTABILITY; HUMANS; MUTATION; NEOPLASMS, COMPLEX AND MIXED;

EID: 33846304642     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (55)

1. Bauer K.H. (1928). Mutationstheorie der Geschwülst-Entstehung/ Mutation Theory in Tumour formation. Julius Springer, Berlin.
2. Beckman R.A. and Loeb L.A. (2005). Genetic instability in cancer: theory and experiment. Semin. Cancer Biol. 15, 423-435.
3. Berenblum I. (1974). Carcinogenesis as a biological problem. Frontiers of Biology, vol 34. North-Holland. Amsterdam. pp 275-321.
4. Bignold L.P. (2002). The mutator phenotype/clonal selection hypothesis can provide a basis for the complex and variable morphological and behavioural features of solid tumour malignancies. Cell. Molec. Life Sci. 59, 950-95.
5. Bignold L.P. (2003). Initiation of genetic instability and tumor formation: a review and hypothesis of a nongenotoxic mechanism. Cell. Mol. Life Sci. 60, 1107-1117.
6. Bignold L.P. (2004). Carcinogen-induced impairment of enzymes for replicative fidelity of DNA and the initiation of tumours. Carcinogenesis 25, 299-307.
7. Bignold L.P. (2005). Embryonic reversions and lineage infidelities in tumour cells: genome-based models and role of genetic instability. Int. J. Exp. Pathol. 86, 67-79.
8. Bignold L.P. (2006). Alkylating agents and DNA polymerases. Anticancer Res. 26 (2B), 1327-1336.
9. Bignold L.P., Coghlan, B.D.L., and Jersmann H.P.A. (2006a). Cancer morphology, carcinogenesis and genetic instability - a background. EXS 96, 1-24.
10. Bignold L.P., Coghlan B.L.D. and Jersmann H.P.A. (2006). Hansemann, Boveri, chromosomes and the gametogenesis-related theories of cancer. Cell Biol. Internat. 30, 640-644.
11. Boveri T. (1914). Zur Frage der Entstehung der Malignen Tumoren. (Jena: G Fischer). Trans M Boveri, and published as "Origin of Malignant Tumors", 1929, (Baltimore: Williams and Wilkins).
12. Brinckerhoff C.E., Rutter J.L. and Benbow U. (2000). Interstitial collagenases as markers of tumor progression. Clin. Cancer Res. 6, 4823-4830.
13. Campisi J. (2005) Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 120, 513-522.
14. Carrio M., Arderiu G., Myers C. and Boudreau N.J. (2005). Homeobox D10 induces phenotypic reversion of breast tumor cells in a three-dimensional culture model. Cancer Res. 65, 7177-7185.
15. Cheng K.C. and Loeb L.A. (1997). Genomic stability and instability: a working paradigm. Curr. Top. Microbiol. Immunol. 221, 5-18.
16. Chidgey M. (2002). Desmosomes and disease: an update. Histol. Histopathol. 17, 1179-1192.
17. Chrenek M.A., Wong P. and Weaver V.M. (2001). Tumour-stromal interactions. Integrins and cell adhesions as modulators of mammary cell survival and transformation. Breast Cancer Res. 3, 224-229.
18. Cox E.C. and Yanofsky C. (1967). Altered base ratios in the DNA of an Escherichia coli mutator strain. Proc. Natl. Acad. Sci. USA 58, 1895-1902.
19. Dobashi Y., Watanabe H. Matsubara M., Yanagawa T., Raz A., Shimamiya T. and Ooi A. (2006). Autocrine motility factor/glucose-6-phosphate isomerase is a possible predictor of metastasis in bone and soft tissue tumors. J. Pathol. 208, 44-53.
20. Duesberg P. (2005). Does aneuploidy or mutation start cancer? Science 307, 41.
21. Duesberg P., Li R., Fabarlus, A. and Hehlmann, R. (2005). The chromosomal basis of cancer. Cell Oncol. 27, 293-318.
22. Erenpreisa J. and Wheatley D. (2005). Endopolyploidy in development and cancer; "survival of the fattest?". Cell Biol. Int. 29, 981-982.
23. Frisch S.M. (1997). The epithelial cell default-phenotype hypothesis and its implications for cancer. Bioessays 19, 705-709.
24. Hansemann D.P. (1890). Ueber asymmetrische Zelltheilung in epithelkrebsen und deren biologische Bedeutung/On the Asymmetrical Division of Cells in Epithelial Carcinomata and their Biological Importance. Virchow's Arch. 119, 299-326.
25. Hansemann D.P. (1891). Ueber pathologische Mitosen./On pathological mitoses. Virchow's Arch. 119, 356-370.
26. Hansemann D.P. (1892). Ueber die Anaplasie der Geschwulstzellen und die asymmetrische Mitrose/ Anaplasia of cancer cells and asymmetrical mitosis. Virchow's Arch. 129, 436-449.
27. Hansemann D.P. (1893). Studien über die Spezificität, den Altruismus und die Anaplasie der Zellen mit besonderer Berücksichtigung der Geschwülste/ Studies of the specificity, altruism and anaplasia of cells with special reference to tumors. (Berlin, A. Hirschwald).
28. Israel O. (1902). Bemerkungen über die Anaplasie von Hansemann's und die Entstehung bösartiger Geschwülste, insbesondere des Carcinoms./ Remarks on Hansemann's anaplasia and the origin of malignant tumours, in particular of carcinoma. Virchow's Arch. 167, 533-537.
29. Koller P.C. (1949). Abnormal mitosis in tumors. Br. J. Cancer 1, 38-47.
30. Koller P.C. (1957). The genetic component of cancer. In: Cancer. Vol 1. Ed RW Raven, Butterworth & Co. London. pp 335-403.
31. Levine M.D., Liotta L.A. and Stracke M.L. (1995). Stimulation and regulation of tumor cell motility in invasion and metastasis. EXS 74, 157-179.
32. Li R., Sonik A., Stindl R., Rasnick D. and Duesberg P. (2000). Aneuploidy vs. gene mutation hypothesis of cancer: recent study claims mutation but is found to support aneuploidy. Proc. Natl. Acad. Sci. USA 97, 3236-3241.
33. Lockhart-Mummery J.P. (1934). The origin of cancer. J & A Churchill. London.
34. Loeb L.A. (1996). Many mutations in cancers. Cancer Surv. 28, 329-342.
35. Loeb L.A. (2001). A mutator phenotype in cancer. Cancer Res. 61, 230-239.
36. Loeb L.A. and Kunkel T.A. (1982). Fidelity of DNA synthesis. Annu. Rev. Biochem. 51, 429-457.
37. Loeb K.R. and Loeb L.A. (2000). Significance of multiple mutations in cancer. Carcinogenesis 21, 379-385.
38. Loeb L.A., Springgate C.F. and Battula N. (1974). Errors in DNA replication as a basis of malignant changes. Cancer Res. 34, 2311-2321.
39. Ludford R.J. (1930). The somatic cell mutation theory of cancer. Sci Rpts Imp Cancer Res Fund, No 9, (London: Taylor and Francis), pp. 121-148.
40. Montell D.J. (2005). Anchors away! Fos fosters anchor-cell invasion. Cell 121, 816-817.
41. Muller H.J. (1922). Variation due to change in the original gene. The American Naturalist 56, 32-50.
42. Murray J.A. (1904). Spontaneous cancer in the mouse. Sci Rpts Imp Cancer Res Fund, No 3, Taylor and Francis, London, pp. 159-174.
43. Nelson R.L. and Mason H.S. (1972). An explicithypothesis for chemical carcinogenesis. J. Theor. Biol. 37, 197-200.
44. Pathak S. and Kultani A.S. (2006). Aneuploidy, stem cells and cancer. EXS 96, 49-64.
45. Rous P. (1959). Surmise and fact on the nature of cancer. Nature 183, 1357-1361.
46. Silletti S. and Raz A. (1996). Regulation of autocrine motility factor receptor expression in tumor cell locomotion and metastasis. Curr. Top. Microbiol. Immunol. 213, 137-169.
47. Speyer J.F. (1965). Mutagenic DNA polymerase. Biochem. Biophys. Res. Commun. 21, 6-8.
48. Stoler D.L., Chen N., Basik M., Kahlenberg M.S., Rodriguez-Bigas M.A., Petrelli N.J. and Anderson G.R. (1999). The onset and extent of genomic instability in sporadic colorectal tumor progression. Proc. Natl. Acad. Sci. USA 96, 15121-15126.
49. Tyzzer E.E. (1916). Tumor immunity. Am. J. Cancer Res. 1, 125-155.
50. Watson J.D. and Crick F.H. (1953). Genetical implications of the structure of deoxyribonucleic acid. Nature 171, 964-967.
51. Weaver D.A. and Cleveland D.W. (2005). Decoding the links between mitosis, cancer, and chemotherapy: The mitotic checkpoint, adaptation, and cell death. Cancer Cell 8, 7-12.
52. Wheelock M.J. and Johnson K.R. (2003). Cadherins as modulators of cellular phenotype. Annu. Rev. Cell Dev. Biol. 19, 207-235.
53. Whitman R.C. (1919). Somatic mutation as a factor in the production of cancer; a critical review of v. Hansemann's theory of anaplasia in the light of modern knowledge of genetics. J. Cancer Res. 4, 181-202.
54. Willis R.A. (1948). Pathology of tumours. Butterworth and Co, London.
55. Wolff J. (1907). Die Lehre von der Krebskrankheit/ The Science of Cancerous Disease from Earliest Times to the Present. Translation by B. Ayoub, and with an Introduction by P. Sarco (1990). (Sagamore Beach, MA, USA: Science History Publishers).